Public signalCompany raiseAuto-indexed · Unverified

Indaptus Therapeutics, Inc. raised $205K

Indaptus Therapeutics, Inc.· NEW YORK, US· Pharmaceuticals· Filed Oct 4, 2024

Indaptus Therapeutics, Inc. reported raising capital. Based in NEW YORK, NEW YORK, US. First sale reported 2024-08-07. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$205,480
Confidence90%
Raised
$205,480
Investors
12
Incorporated
2021
Jurisdiction
DELAWARE

On the record

Location
NEW YORK, US
Sector
Pharmaceuticals
Record type
Company raise
Stage
Reported raised
Amount raised
$205,480
Target amount
$205,480
Filing date
Oct 4, 2024
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Year incorporated
2021
Industry group
Pharmaceuticals
Number of investors
12
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$205,480
Amendment
Yes

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 205,480 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Oct 4, 2024. Details beyond the filing have not been verified.

Tags

AmendmentUSCompanyPharmaceuticals$100K – $1MCompany Raise

Are you associated with Indaptus Therapeutics, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record